Literature DB >> 19130742

Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.

M Jeub1, M Bitoun, P Guicheney, K Kappes-Horn, K Strach, K F Druschky, J Weis, D Fischer.   

Abstract

Centronuclear myopathy (CNM) is a slowly progressive congenital myopathy with characteristic histopathological findings of chains of centrally located myonuclei in a large number of muscle fibers. Recently, different missense mutations in the dynamin 2 gene (DNM2, 19p13.2) have been shown to cause autosomal dominant CNM. We re-evaluated patients with a histopathological diagnosis of CNM and report on the clinical phenotype, the biopsy findings and the genetic results of these patients and review the current literature. Two of the three patients showed an unusually late disease onset (> 40 years). Interestingly, intramuscular nerve fascicles found in the muscle biopsy of a patient harboring the E368K DNM2 mutation contained nerve fibers with disproportionately thin myelin sheaths. Schwann cells of unmyelinated nerve fibers showed abnormal plasma membrane and basal lamina protrusions, indicating peripheral nerve involvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19130742     DOI: 10.5414/npp27430

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  20 in total

1.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

2.  Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.

Authors:  F Hanisch; T Müller; A Dietz; M Bitoun; W Kress; J Weis; G Stoltenburg; S Zierz
Journal:  J Neurol       Date:  2011-01-09       Impact factor: 4.849

3.  Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.

Authors:  Yan Zhao; Zhe Zhao; Hongrui Shen; Qi Bing; Jing Hu
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

4.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

5.  Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.

Authors:  Johann Böhm; Valérie Biancalana; Elizabeth T Dechene; Marc Bitoun; Christopher R Pierson; Elise Schaefer; Hatice Karasoy; Melissa A Dempsey; Fabrice Klein; Nicolas Dondaine; Christine Kretz; Nicolas Haumesser; Claire Poirson; Anne Toussaint; Rebecca S Greenleaf; Melissa A Barger; Lane J Mahoney; Peter B Kang; Edmar Zanoteli; John Vissing; Nanna Witting; Andoni Echaniz-Laguna; Carina Wallgren-Pettersson; James Dowling; Luciano Merlini; Anders Oldfors; Lilian Bomme Ousager; Judith Melki; Amanda Krause; Christina Jern; Acary S B Oliveira; Florence Petit; Aurélia Jacquette; Annabelle Chaussenot; David Mowat; Bruno Leheup; Michele Cristofano; Juan José Poza Aldea; Fabrice Michel; Alain Furby; Jose E Barcena Llona; Rudy Van Coster; Enrico Bertini; Jon Andoni Urtizberea; Valérie Drouin-Garraud; Christophe Béroud; Bernard Prudhon; Melanie Bedford; Katherine Mathews; Lori A H Erby; Stephen A Smith; Jennifer Roggenbuck; Carol A Crowe; Allison Brennan Spitale; Sheila C Johal; Anthony A Amato; Laurie A Demmer; Jessica Jonas; Basil T Darras; Thomas D Bird; Mercy Laurino; Selman I Welt; Cynthia Trotter; Pascale Guicheney; Soma Das; Jean-Louis Mandel; Alan H Beggs; Jocelyn Laporte
Journal:  Hum Mutat       Date:  2012-04-04       Impact factor: 4.878

6.  Protein partners of dynamin-1 in the retina.

Authors:  Gregory H Grossman; Lindsey A Ebke; Craig D Beight; Geeng-Fu Jang; John W Crabb; Stephanie A Hagstrom
Journal:  Vis Neurosci       Date:  2013-06-10       Impact factor: 3.241

7.  Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.

Authors:  Elizabeth M Gibbs; Nigel F Clarke; Kristy Rose; Emily C Oates; Richard Webster; Eva L Feldman; James J Dowling
Journal:  J Mol Med (Berl)       Date:  2013-01-22       Impact factor: 4.599

Review 8.  [Neurogenic muscular atrophy and selective fibre type atrophies : Groundbreaking findings in the biopsy diagnosis of neuromuscular disease].

Authors:  J Weis; S Nikolin; K Nolte
Journal:  Pathologe       Date:  2009-09       Impact factor: 1.011

9.  Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.

Authors:  Kristl G Claeys; Stephan Züchner; Marina Kennerson; José Berciano; Antonio Garcia; Kristien Verhoeven; Elsdon Storey; John R Merory; Henriette M E Bienfait; Martin Lammens; Eva Nelis; Jonathan Baets; Els De Vriendt; Zwi N Berneman; Ilse De Veuster; Jefferey M Vance; Garth Nicholson; Vincent Timmerman; Peter De Jonghe
Journal:  Brain       Date:  2009-06-05       Impact factor: 13.501

10.  Impaired excitation-contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy.

Authors:  Candice Kutchukian; Peter Szentesi; Bruno Allard; Delphine Trochet; Maud Beuvin; Christine Berthier; Yves Tourneur; Pascale Guicheney; Laszlo Csernoch; Marc Bitoun; Vincent Jacquemond
Journal:  J Physiol       Date:  2017-11-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.